Brief: Morphosys' Management And Supervisory Board Recommend Shareholders Accept Takeover Offer By Novartis

Morphosys AG

11/04/2024 13:43

April 11 (Reuters) - MORPHOSYS AG  MORG.DE :
    * MORPHOSYS’ MANAGEMENT BOARD AND SUPERVISORY BOARD 
RECOMMEND
SHAREHOLDERS ACCEPT PUBLIC TAKEOVER OFFER BY  NOVARTIS
    * NOVARTIS OFFERS EUR 68.00 PER SHARE IN CASH, REPRESENTING
A
TOTAL EQUITY VALUE OF EUR 2.7 BILLION
    * ACCEPTANCE PERIOD HAS COMMENCED AND WILL END ON MAY 13,
2024, AT
24:00 HOURS CEST
    * MORPHOSYS AND NOVARTIS MAINTAIN THEIR EXPECTATION THAT
CLOSING
OF TAKEOVER OFFER WILL TAKE PLACE IN FIRST HALF OF 2024.
    * MORPHOSYS AND NOVARTIS HAVE AGREED TO DELIST MORPHOSYS
SHARES IN
GERMANY AND IN U.S. IMMEDIATELY AFTER PUBLIC TAKEOVER OFFER HAS
BEEN SETTLED

Source text for Eikon:  ID:nEQ4phGx1a 
Further company coverage:  MORG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))